Completed PHASE2 INTERVENTIONAL 3-arm NCT02356965

Study Testing Ketamine Sublingual Wafer After Wisdom Tooth Extraction

A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Dose Ranging Study to Assess the Analgesic Efficacy, Tolerability, Safety and Pharmacokinetic/Pharmacodynamic Properties of A Sublingual Wafer Formulation of Ketamine Following Third Molar Extraction

Sponsor: Jean Brown Research

Conditions Pain

Interventions Ketamine Placebo (for Ketamine)

Updated 6 times since 2017 Last updated: Mar 24, 2015 Started: Dec 31, 2014 Primary completion: Feb 28, 2015 Completion: Feb 28, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Pain and is currently completed. Jean Brown Research leads this study, which shows 6 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Dec 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Jean Brown Research
Lotus Clinical Research, LLC
iX Biopharma Ltd.

Data source: iX Biopharma Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Salt Lake City, United States